Phytosterol Composition for Adult Stem Cell Activation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Adult organisms have limited ability to regenerate tissues and restore immune responses due to quiescent stem cells not being effectively activated for tissue repair or immune function, especially in cases of pathology or aging, where existing stem cells do not efficiently proliferate and differentiate to replace damaged cells.
Innovation Solution
A pharmaceutical composition comprising a mixture of phytosterols, preferably with 24-methylene-cholesterol and cholesterol, administered transdermally or transmucosally, which activates quiescent stem cells to proliferate and differentiate, mimicking the regenerative capabilities of embryonic stem cells, thereby regenerating tissues and restoring immune function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If adult stem cells are used for tissue regeneration, then the treatment avoids ethical issues and immune rejection, but the regenerative capability is insufficient due to limited proliferation and differentiation of quiescent stem cells
Solution Approach 1:
The patent applies parameter changes by modifying the chemical environment through phytosterol administration. The phytosterols change the physiological parameters of the adult stem cells, inducing them to exit quiescence and proliferate. This resolves the contradiction by chemically activating the stem cells to achieve embryonic-like regenerative capability without the ethical and immunological issues of embryonic stem cells
Solution Approach 2:
The phytosterols act as intermediaries between the external environment and the adult stem cells. These compounds mediate the activation process by binding to androgen receptors on stem cells, triggering proliferation and differentiation signals. This intermediary mechanism enables the activation of adult stem cells to achieve high regenerative capability without directly manipulating the cells
2Reliability
If embryonic stem cells are used for complete tissue regeneration, then the regenerative potential is high, but ethical problems and immune rejection occur
Solution Approach 1:
The patent copies the regenerative mechanism of embryonic stem cells using adult stem cells instead. By administering phytosterols, the adult stem cells are induced to proliferate and differentiate with embryonic-like efficiency. This copying approach achieves complete tissue regeneration while avoiding the ethical and immunological problems associated with actual embryonic stem cell use
Solution Approach 2:
The invention enables adult stem cells to serve themselves by activating their intrinsic regenerative potential. The phytosterols trigger the stem cells to self-proliferate and self-differentiate into needed tissue types. This self-service mechanism eliminates the need for external embryonic stem cell sources, avoiding ethical issues and immune rejection while achieving complete regeneration
3Productivity
If quiescent stem cells are activated for proliferation, then tissue regeneration is enhanced, but the systemic immune response may be disrupted
Solution Approach 1:
The patent applies local quality by targeting stem cell activation specifically at the site of tissue damage rather than systemically. The phytosterols are applied locally (transdermally or transmucosally) and activate stem cells in the affected district. This localized activation enhances tissue regeneration while minimizing disruption to the overall systemic immune response, as the immune system continues to function normally in unaffected areas
Data Source
AI summary
Use of a mixture of phytosterols, selected from the group comprising: brassicasterol (Delta 5-C22 unsaturated); campesterol; campestanol; stigmasterol (Delta 5-C22 unsaturated); Delta 5-C23-stigmastadienol; clerosterol (Delta 8-C25 unsaturated); Beta-sitosterol; sitostanol; Delta 5-venasterol (Delta 5-C24 unsaturated); Delta 5-C24-stigmastadienol (Delta 5-C24 diene unsaturated); Delta 7-stigmastenol; 24-methylene-cycloartenol; gramisterol; 24-methylcholest-7-enol; isofucosterol; Delta 7-avenasterol (Delta 7-C24 unsaturated); Delta 5-avenastenol, for the manufacture of a medicament to induce into the adult organism proliferation and differentiation of the stem cells which are present in the organism.